Pyoderma gangrenosum: a too often overlooked facultative paraneoplastic disease.
The frequency of concomitant malignant disease in PG patients has been estimated at 4.5-9% [[1]], and there have been increasing reports of PG in patients with an underlying solid malignancy [[2]] leading us to further characterize this association. Mortality was further analyzed using a univariate...
| Publicado en: | Annals of Hematology Vol. 98; no. 9; pp. 2247 - 2249 |
|---|---|
| Autores principales: | , |
| Formato: | review Journal Article |
| Publicado: |
Springer Nature
Sep2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=138140335&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 138140335 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09395555 1WU jtl: Annals of Hematology issn: 09395555 maglogo: N pubinfo: dt: Sep2019 vid: 98 iid: 9 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 138140335 138140335 143960401 NLM31230113 138140335 10.1007/s00277-019-03732-9 NLM31230113 138140335 ppf: 2247 ppct: 2 formats: tig: atl: Pyoderma gangrenosum: a too often overlooked facultative paraneoplastic disease. aug: au: Gupta, Angela S. Ortega-Loayza, Alex G. affil: Virginia Commonwealth University School of Medicine, Richmond, VA, USA sug: subj: Pyoderma Gangrenosum Diagnosis Pyoderma Gangrenosum Pathology Paraneoplastic Syndromes Metabolism Paraneoplastic Syndromes Diagnosis Paraneoplastic Syndromes Pathology Pyoderma Gangrenosum Metabolism Diagnosis, Differential Male Female Male Female ab: The frequency of concomitant malignant disease in PG patients has been estimated at 4.5-9% [[1]], and there have been increasing reports of PG in patients with an underlying solid malignancy [[2]] leading us to further characterize this association. Mortality was further analyzed using a univariate logistic regression model which determined that patients with leukemia and PG have a higher likelihood of death compared with PG patients with non-leukemia hematologic malignancies ( I p i < 0.05, 95% CI = 1.01-3.34). <table frame="hsides" rules="groups"><thead><tr><th /><th>PG diagnosed before (%)</th><th>PG diagnosed after (%)</th><th>PG diagnosed at the same time (%)</th></tr></thead><tbody><tr><td>Hematologic malignancy</td><td>25</td><td>54</td><td>21</td></tr><tr><td>Solid malignancy</td><td>17</td><td>71</td><td>12</td></tr></tbody></table>. pubtype: Academic Journal doctype: review Journal Article ougenre: Unknown language: English refInfo: holdings: @attributes: islocal: N |
|---|